Header Logo

Connection

STACEY BERG to MAP Kinase Signaling System

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about MAP Kinase Signaling System.
STACEY BERG
Connection Strength
0.051
MAP Kinase Signaling System
  1. Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. JCO Precis Oncol. 2024 Jun; 8:e2400103.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.